Covered recipient · General Payments record
KATHERINE E DUNCAN
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$1,689.02
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $379.93 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $189.70 | 9 |
| Alcon Laboratories Inc | $48.58 | 2 |
| Tarsus Pharmaceuticals, Inc. | $37.53 | 1 |
| Dompe US, Inc. | $31.52 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $31.48 | 2 |
| Bausch & Lomb Americas Inc. | $24.17 | 1 |
| Astellas Pharma US Inc | $16.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alcon Vision LLC | $23.18 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110634137 | CMS |
| Alcon Vision LLC | $25.40 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110634139 | CMS |
| Amgen Inc. | $28.62 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111566677 | CMS |
| Amgen Inc. | $25.98 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111566679 | CMS |
| Amgen Inc. | $30.39 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111566681 | CMS |
| Amgen Inc. | $24.52 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111566683 | CMS |
| Amgen Inc. | $29.22 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111566687 | CMS |
| Amgen Inc. | $10.60 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111566685 | CMS |
| Amgen Inc. | $5.97 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111566689 | CMS |
| Amgen Inc. | $30.40 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111566691 | CMS |
| Amgen Inc. | $4.00 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111566693 | CMS |
| Astellas Pharma US Inc | $16.95 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139425703 | CMS |
| Bausch & Lomb Americas Inc. | $24.17 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140382806 | CMS |
| Dompe US, Inc. | $31.52 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151407961 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $14.11 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152167450 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $17.37 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152167452 | CMS |
| Tarsus Pharmaceuticals, Inc. | $37.53 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139093867 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.